Puma Biotechnology Sees Q3 Sales $48.000M-$51.000M vs $60.000M Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Puma Biotechnology (NASDAQ:PBYI) sees Q3 sales of $48.000 million-$51.000 million vs $60.000 million analyst estimate.
Puma Biotechnology (NASDAQ:PBYI) sees Q3 sales of $48.000 million-$51.000 million vs $60.000 million analyst estimate.